Transplantation Flashcards

1
Q

Why are organs transplanted?

A

Transplantations occur when organs are failing or have failed, or for reconstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two reasons for transplantation? Including examples.

A

LIFE-SAVING (when other life-supportive methods have reached the end of their use e.g. liver, heart and left ventricular assist device, and small bowel and total parenteral nutrition), and LIFE-ENHANCING (when other life-supportive methods are less good e.g. kidney and dialysis, pancreas and insulin injections; OR when organ is not vital but it will improve quality of life e.g. eye and reconstructive surgery).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference in long-term survival between transplanted organs from a living and deceased organ?

A

Living donor transplant has higher survival rates in the long-term than from deceased donors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why do organs fail: cornea (x3), skin (x4), bone marrow (x2), kidney (x4), liver (x2), heart (x3), lung (x3), pancreas (x1) and small bowel (x5)?

A

 CORNEA: degenerative disease, infections and trauma.  SKIN: burns, trauma, infections and tumours.  BONE MARROW: tumours and hereditary diseases.  KIDNEY: diabetes, hypertension, glomerulonephritis and hereditary conditions.  LIVER: cirrhosis (hepatitis, alcohol, autoimmune, hereditary) and acute liver failure (paracetamol).  HEART: coronary artery or valve disease, cardiomyopathy and congenital defects.  LUNGS: COPD (smoking, environmental), interstitial lung disease (autoimmune, environmental), cystic fibrosis (hereditary).  PANCREAS: T1DM.  SMALL BOWEL: volvulus, gastroschisis, necrotising enteritis related to prematurity, Crohn’s disease, cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the five types of transplantation?

A

□ AUTOGRAFTS: within the same individual e.g. skin, cardiac bypass surgery, or generating organs from own stem cells (this is experimental and is a developing area of medicine). □ ISOGRATS: between two genetically identical individuals of the same species. □ ALLOGRAFTS: between individuals of the same species. □ XENOGRAFTS: between individuals of different species (heart valves from pigs and cows). □ PROSTHETIC GRAFT: plastic, metal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the two types of donor?

A

Deceased donor and living donor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What type of organs can liver donor donate?

A

Only a limited number of organs, because something like a heart cannot be donated without the patient dying. Organs that can be donated from a living person include bone marrow, kidney and liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two types of deceased donor? Which one is advantageous?

A

□ DBD – DONOR AFTER BRAIN STEM DEATH: majority of organ donors. Where brain injury has caused death before terminal apnoea has resulted in cardiac arrest and circulatory standstill. Occurs as a result of RTCs and intracranial haemorrhage. In these donors, the circulation has been established and sustained through resuscitation, but they are brain dead. This maintenance of circulation is advantageous because it reduces to chance of organ ischaemia. DEATH IS CONFIRMED USING NEUROLOGICAL CRITERIA. □ DCD – DONOR AFTER CIRULATORY DEATH: death occurs because of cardio-respiratory causes. Usually, it is controlled (people taken off life support) but can sometimes be uncontrolled (resuscitation unsuccessful). DEATH IS CONFIRMED USING CARDIO-RESPIRATORY CRITERIA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What must be checked from deceased donors before their organs are donated? (x4)

A

Viral infections, malignancy, drug abuse/overdose/poison, and disease of the transplanted organ must be EXCLUDED.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How are donated organs processed before donation?

A

They are rapidly cooled and perfused. This cannot be done for long – the process is used because it SLOWS DOWN ischaemia; it doesn’t stop it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is needed for ethical transplant allocation? (x2)

A

□ EQUITY: what is fair? This considers factors such as time on waiting list, urgency of transplant. □ EFFICIENCY: what is the best use of the organ in terms of patient and graft survival. This considers factors such as match.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What tools are used to decide transplant allocation? (x2)

A

National guidelines and evidence-based computer algorithm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the criteria for organ allocation? (x5)

A

□ WAITING TIME. □ HLA MATCH AND AGE COMBINED. □ DONOR-RECIPIENT AGE DIFFERENCE. □ AGE OF PATIENT. □ Blood group match.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Organ Donation Taskforce?

A

UK Government organisation set up to identify barriers in organ donation and recommend actions to increase organ donation and procurement.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is NHS Blood and Transplant?

A

Provides blood and organs to the NHS. It also establishes rules for organ allocation and monitors allocation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which chromosome is the MHC transcribed from?

A

Coded from HLA gene (human leukocyte antigens) on Chromosome 6.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the two mechanisms of transplant rejection?

A

From mismatched ABO blood group, and from HLA (and MHC).

18
Q

What is the mechanism of ABO-incompatible transplant rejection?

A

□ RBCs have A and B proteins with carbohydrate chains – these are the ABO antigens. Endothelial lining of blood vessels in transplanted organs also have these antigens.

□ Our body produces anti-AB antibodies depending on blood group. In blood group AB, you produce none of these antibodies (see photo).

□ This means that donated organs from a donor with a different blood group to the recipient develops an immune response to the donated organ (unless recipient is AB, or donor is O): The recipient’s antibodies mediates rejection by binding to ABO antigens on donor endothelium.

□ Microcirculation is therefore thrombosed, and organ cannot be perfused –> dies.

19
Q

How do you overcome ABO-incompatible transplantation?

A

Remove antibodies in the recipient with plasma exchange. This has good outcomes, even if the antibody comes back (we don’t understand why this is).

20
Q

What is the mechanism of HLA-incompatible transplant rejection?

A

□ MHC (from the HLA gene) is found on cell surface and are highly variable between individuals. The variability of HLA molecules is important in defence against infections and neoplasia.

□ In donated organs, the donor graft cells shed their (foreign) HLA proteins into the circulation.

□ These foreign HLA proteins are taken up by APCs, broken down, and presented to immune cells as peptides by the donor’s own HLA proteins (in the peptide groove).

□ CD4+ T lymphocytes recognise these peptides in APCs and become stimulated. An ANTIBODY RESPONSE is subsequently mounted against the organ.

□ The immune reaction causes immune graft damage and failure = REJECTION.

21
Q

What are the two types of HLA?

A

□ Class I (from A, B, C HLA genes) is expressed on all cells. MCH Class I molecules hold out a sample of the internal cell contents for CD8 T cells. □ Class II (DR, DQ, DP) is expressed on antigen-presenting cells but also upregulated on other cells – mediated by CD4 T cells.

22
Q

How do the general responses of activated CD4 and CD8 T cells differ?

A

CD4 activates an antibody response; CD8 responds by directly killing cells.

23
Q

What are the characteristics of HLA genes? (x3 points)

A

□ MHC is POLYGENIC with several class I and II loci i.e. there is more than one gene locus involved in expression of MHC. □ Expression of MHC is CO-DOMINANT meaning that maternal and paternal genes both expressed. □ Human MHC genes are highly POLYMORPHIC: meaning there are lots of different alleles (thousands) for the same gene in the population. These alleles are LINKED on the SAME chromosome (Chr 6) – this collection of alleles is called MHC HAPLOTYPE.

24
Q

What is the structure of MHC Class I?

A

□ Has one transmembrane and cytoplasmic region.

□ Has three domains: alpha 1, 2 and 3 – comprising the heavy chain of the MHC.

□ The B2-microglobulin is the light chain – NON-COVALENTLY associated with the heavy chain.

□ The alpha 3 domain and B2-microglobulin are similar in structure to Ig – so are part of the immunoglobulin super-family.

□ The bit that binds the peptide (the thing the MHC holds out for T cells) is between the alpha 1 and 2 regions. This region can only hold peptides of 8-10 amino acids.

25
What is the structure of MHC Class II?
□ Like MHC Class I, there are two polypeptides, but they are both the same size (one polypeptide has alpha 1 and 2, the other beta 1 and 2 – unlike MHC Class I which has alpha 1, 2 and 3, and B2-microglobulin). □ Has two transmembrane and cytoplasmic regions. □ Peptide binding region is the same. This region can hold peptides of more than 13 amino acids.
26
How is HLA matching assessed in transplantation?
The HLA-A, HLA-B and HLA-DR alleles are compared between the recipient and donor (this is because these are most polymorphic). There are two alleles expressed in each of these genes (obviously), so there are 6 possible mismatches between the recipient and donor in this assessment. In the example, there are 3 mismatches between the HLAs, which is written as MM 1:2:0.
27
What is the chance that there is 0MM between siblings?
Look at the gene diagram in the photo. There is 25% there is 6MM, 50% chance there is 3MM, and 25% chance there is 0MM.
28
How is rejection diagnosed?
Diagnosis by histological examination of a graft biopsy.
29
How is rejection treated?
Immunosuppressive drugs.
30
What are the characteristics of a rejected kidney in a graft biopsy? (x3)
Lymphocyte interstitial infiltration (accumulation of lymphocytes in the kidney), ruptured tubular basement membrane (where lymphocytes can now enter the kidney tissue) and tubulitis (immune response to the kidney tubules).
31
How is rejection classified? (x2 (x3 and x2))
□ Hyperacute, acute and chronic (slow deterioration of function) rejection. Hyperacute occurs usually in mistakes, when there is complete mismatch between recipient and donor. □ T-cell mediated and antibody-mediated rejection.
32
What happens in T-cell mediated rejection?
Donated cells shed HLA proteins (foreign). These are presented in local lymph nodes by antigen presenting cells which migrate to lymphoid organs. Naïve and central T cells recirculate between secondary lymphoid organs and meet APCs. Here, they are activated. Once activated, they recirculate and return to the donated organ and reject it.
33
What do the CD4+ T cells do in their immune response against a graft organ?
□ They differentiate into distinct subsets after antigen encounter (T helper 1 cells (Th1), Th2, follicular helper cells (Tfh), Th17 and Treg cells), activate macrophages and ACTIVATE B CELLS. CD4’s general action is to activate an ANTIBODY RESPONSE. □ Activated macrophages phagocytose, release proteolytic enzymes, produce cytokines and produce oxygen and nitrogen radicals. □ CD8+ T cells can also be activated (cytotoxic T cells) which release toxins (including Granzyme B) which KILL TARGET DIRECTLY, punch holes in target cell (using perforin) and trigger apoptotic death (with Fas ligand).
34
What happens in antibody-mediated rejection? Two types?
□ Occurs when antibody is produced against graft HLA or AB antigen of blood/endothelium. □ Antibodies can arise pre-transplantation (‘sensitised’ – patients who already have antibodies against certain HLA proteins, typically in patients with a lot of previous exposure e.g. previous transplant, pregnant women with their foetus, blood transfusions) or post-transplantation (‘de novo’). □ Antibody binds to antigen, activating complement and macrophages – leading to necrosis and coagulation. □ Mediated by B cells.
35
How is post-transplantation rejection monitored? (x2)
Deteriorating graft function is monitored e.g. creatinine levels, fluid retention and hypertension in kidney transplant recipients; rise in LFTs (liver function tests) in liver transplant recipients; and breathlessness or pulmonary infiltrate (such as pus, protein or blood) in lung transplant recipients. In some organs, deteriorating function cannot be monitored e.g. heart, so biopsies must be taken.
36
How do reduce risk of rejection? (x2)
Maximise HLA compatibility and life-long immunosuppressive drugs.
37
What are the two types of immunosuppressive drugs?
□ TARGETING T CELL ACTIVATION AND PROLIFERATION: Antigen presenting cell-T cell interaction is targeted (this is responsible for T cell activation). Drugs target the direct signalling between MHC on APC and TCR, as well as the co-stimulation and interleukin interactions which are needed for T cell activation. □ TARGETING B CELL ACTIVATION AND PROLIFERATION, AND ANTIBODY PRODUCTION: Drugs remove antibodies or deplete the numbers of B and plasma cells. Some also target complement activation.
38
What is the standard immunosuppressive regime? (x3 steps)
1. PRE-TRANSPLANTATION: an induction agent is administered to prepare the immune system. Usually T-cell depletion drug or cytokine blockade to block T-cell mediated rejection. 2. AFTER TRANSPLANTATION: base-line immunosuppression. Signal transduction blockade, antiproliferative agents and corticosteroids are administered. 3. IF, DURING MONITORING, THERE ARE EPISODES OF ACUTE REJECTION: extra drugs are administered based on the physiology of the rejection i.e. T or B-cell mediated.
39
How is the risk of post-transplantation infections reduced?
Increased risk of infection is combatted by prophylactic anti-viral therapy in all transplant patients.
40
What is the post-transplantation risk of malignancy? (x2)
There is increased risk of SKIN cancer and LYMPHOPROLIFERATIVE DISORDERS (usually Epstein Barr virus driven – a herpesvirus).
41
What is an orthotopic transplant?
When organ is transplanted into the same place it is found in a normal individual – such that the failed organ must first be removed.
42
What is a heterotopic transplant?
When organ is transplanted into an area of the body differing from its normal position e.g. kidney transplant. In these cases, the failed organ does not need to be removed.